NAFTA negotiations grind on, little sign of quick breakthrough
January 25, 2018Wall St. surrenders gains after Trump talks up dollar
January 25, 2018Exclusive: J&J out of race for Pfizer’s $20 billion consumer unit as deadline looms
at
LONDON/NEW YORK/FRANKFURT (Reuters) – Johnson & Johnson has pulled out of the race to buy Pfizer’s consumer health business, leaving GlaxoSmithKline and Reckitt Benckiser among those preparing bids, according to sources familiar with the matter.
Powered by WPeMatico
